Alnylam Pharmaceuticals Inc (ALNY)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
34,249,783,000
EV to revenue ratio (TTM)
6.58
EV to ebitda
28.62
Financial Performance
Revenue (TTM)
4,804,182,000
Gross profit (TTM)
3,826,732,000
EBITDA
1,054,538,000
Profitability
Operating margin (TTM)
17.90%
Profit margin
16.10%
Return on assets (TTM)
12.30%
Return on equity (TTM)
96.60%
Per Share Metrics
Revenue per share (TTM)
36.24
EPS
5.73
Diluted EPS (TTM)
5.73
Book value
10.12
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
44.67
Trailing P/E
44.67
Forward P/E
19.68
PEG ratio
0.325
Price to sales ratio (TTM)
7.13
Price to book ratio (TTM)
24.87
Growth
Quarterly earnings growth (YoY)
66.90%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
7
Buy
16
Hold
6
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.3